Home › Alcohol Use Disorder (AUD) › NCT07217795
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
Developing a Telehealth Intervention for Alcohol and Trauma Among LGBTQ+ People
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Aim 1: Sexual Minority Women and Transgender and Gender Diverse Individuals -Not meeting inclusion criteria Aim 1: Providers -Not meeting inclusion criteria Aim 2: Sexual Minority Women and Transgender and Gender Diverse Individuals * Not meeting inclusion criteria OR any of the following: * Reporting current mental health treatment ≥1 day/month * Receiving Cognitive Behavioral Therapy (CBT) in the past 3 months (note: participants are not ineligible if they seek concomitant care after enrollment) * Reporting current alcohol or drug use disorder treatment, except mutual self-help (e.g., Alcoholics Anonymous) or current PTSD/trauma-focused treatment * Need for alcohol detoxification, defined as score ≥15 on the adapted self-report Clinical Institute Withdrawal Assessment for Alcohol - Revised (CIWA-Ar) * Active psychosis, defined as score ≥1 on the psychosis subscale of the Behavior and Symptom Identification Scale - Revised (BASIS-R) * Active mania, defined as score ≥6 on the Altman Self-Rating Mania Scale (ASRM) * Active suicidality, defined as score ≥22 on the Suicidal Ideation Attributes Scale (SIDAS) * Currently legally mandated to attend treatment
About the study
This is a two-part study to develop and test a brief, virtual therapy program for lesbian, gay, bisexual, transgender, and queer (LGBTQ+) people who have experienced trauma and use alcohol.
Phase 1: You'll be invited to share your perspective to help make the program relevant, inclusive, and affirming.
Phase 2: You may have the opportunity to try the adapted program by receiving free virtual therapy with LGBTQ+-affirming therapists.
What is being tested
- CBT + expressive writing (behavioral)
- Wait-List Control (behavioral)
Sponsor: University of Rhode Island · Participants: 80 · Started: Nov 30, 2025
Contact the study team
- Jillian Scheer, PhD · Phone: 401-874-2193
Official record on ClinicalTrials.gov — NCT07217795
Locations in the U.S.
| Rhode Island | University of Rhode Island, Providence |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.